Russia, which became the first country to register coronavirus vaccine called Sputnik V, will release the vaccine trial data likely by Monday.
Russia will soon release data on pre-clinical and clinical studies of the new coronavirus vaccine that was approved earlier this week. “Data on preclinical and clinical studies will be published in the coming days, possibly by Monday,” said news agency reported, citing health minister Mikhail Murashko.
The development has also come at a time when scientists across the globe are skeptical and not very sure about the vaccine developed by Russia doubting its effectiveness. Meanwhile, a senior expert of the World Health Organization (WHO) said that it is currently in conversation with Russia to get additional information about the coronavirus vaccine that Russia will start production soon.
Dr. Bruce Aylward, senior adviser to WHO’s director-general, told in a press conference on Thursday that WHO does not have sufficient information at this point to make a judgment on the Russian vaccine.
He told reporters that with the coordination of WHO, there are altogether nine vaccine candidates that are going through Phase 2 or 3 trials, but the Russian vaccine is not one of them.
Russian President Vladimir Putin announced Tuesday that the country has registered the world’s first registered vaccine against the novel coronavirus.
Later on Wednesday, Russian Health Minister Mikhail Murashko said that the country will start the production of the vaccine within two weeks. Murashko also said that doubts about the effectiveness of the vaccine are unfounded.